HASSAN EMIL E 4
4 · NATIONAL HEALTHCARE CORP · Filed May 6, 2022
Insider Transaction Report
Form 4
HASSAN EMIL E
Director
Transactions
- Exercise/Conversion
Shares of Common Stock
2022-05-05$72.94/sh+7,500$547,050→ 78,595 total - Exercise/Conversion
Option to Purchase Common Stock
2022-05-05−7,500→ 0 totalExercise: $72.94From: 2017-05-09Exp: 2022-05-08→ Common Stock (7,500 underlying) - Award
Option to Purchase Common Stock [2022 Grant]
2022-05-05+7,500→ 7,500 totalExercise: $69.19From: 2023-05-05Exp: 2027-05-04→ Common Stock (7,500 underlying)
Holdings
- 7,500
Option to Purchase Common Stock
Exercise: $61.90From: 2018-05-03Exp: 2023-05-02→ Common Stock (7,500 underlying) - 7,500
Option to Purchase Common Stock
Exercise: $64.64From: 2021-05-07Exp: 2025-05-06→ Common Stock (7,500 underlying) - 7,500
Option to Purchase Common Stock
Exercise: $71.64From: 2022-05-06Exp: 2026-05-05→ Common Stock (7,500 underlying) - 7,500
Option to Purchase Common Stock
Exercise: $77.92From: 2019-05-09Exp: 2024-05-08→ Common Stock (7,500 underlying)
Footnotes (2)
- [F1]These stock options were granted pursuant to the 2010 Omnibus Equity Incentive Plan on May 9, 2017. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d).
- [F2]These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on May 5, 2022. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d).